title: Should Sentinel Lymph Node Biopsy for Patients with Early Breast Cancer Be Abandoned? Not So Fast.
abstract: As major advances are made in the management of early breast cancer, the role of sentinel lymph node biopsy (SLNBx) has been called into question. However, before abandoning SLNBx, a critical appraisal of its role should be done because we believe that it remains a critical component of care, especially when tailoring patient's adjuvant therapy. This commentary provides cogent arguments in favor of SLNBx in the management of patients with early breast cancer.
authors.affiliation: Department of Surgery, Louisiana State University Health Sciences Center, Shreveport, LA, USA.; Professor and Chief of Surgical Oncology Charles D. Knight, Sr. Endowed Professor of Surgery Director, Vice-Chair of Academic Affairs, Peritoneal Surface Malignancies Program, Feist-Weiller Cancer Center, LSU-Health Sciences Center-Shreveport, Shreveport, LA, USA.
authors.forename: Quyen D
authors.initials: QD
authors.lastname: Chu
authors.affiliation: Department of Medicine, The Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA, USA.; Assistant Professor of Medicine, Division of Hematology and Oncology, Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA, USA.
authors.forename: Prakash
authors.initials: P
authors.lastname: Peddi
keywords: sentinel node early breast cancer; sentinel node importance; sentinel node relevance